---
title: "Evergrande Life Insurance's three chairmen and 20 senior executives were penalized: involved in the use of insurance funds, interest transfer, and other issues"
description: "The fines disclosed by the National Financial Regulatory Administration show that 20 relevant responsible personnel of Evergrande Life Insurance Co., Ltd. have been penalized. According to the reasons"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/257088359.md"
published_at: "2025-09-12T11:07:01.000Z"
---

# Evergrande Life Insurance's three chairmen and 20 senior executives were penalized: involved in the use of insurance funds, interest transfer, and other issues

> The fines disclosed by the National Financial Regulatory Administration show that 20 relevant responsible personnel of Evergrande Life Insurance Co., Ltd. have been penalized. According to the reasons for the penalties, the fines indicate that the responsible personnel of Evergrande Life Insurance were involved in serious non-compliance in the use of insurance funds, transferring benefits to related parties, non-compliance in post-investment management, and false records in the submitted reports and statements, among other illegal and regulatory violations

The fines disclosed by the National Financial Regulatory Administration show that 20 relevant responsible personnel of Evergrande Life Insurance Co., Ltd. have been penalized. Regarding the reasons for the penalties, the fines indicate that the responsible personnel of Evergrande Life Insurance have engaged in serious non-compliance in the use of insurance funds, provided benefits to related parties, violated post-investment management regulations, and submitted reports with false records and other illegal activities

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | [Link](https://longbridge.com/en/news/276024005.md) |
| Shenhua Energy Gets Securities Regulator's Nod for Share Placement Plan | Shenhua Energy Gets Securities Regulator's Nod for Share Placement Plan | [Link](https://longbridge.com/en/news/275851575.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/en/news/276016059.md) |
| Canada's Manulife Q4 core earnings rise 5% | Canada's Manulife reported a 5% year-over-year increase in Q4 core earnings, with adjusted EPS surpassing analyst expect | [Link](https://longbridge.com/en/news/275667029.md) |
| Retal Urban Development Signs SSA With Alfozan Holding For Ajdan Co Shares | Retal Urban Development Company SJSC :RETAL URBAN DEVELOPMENT - SIGNS SHARE SWAP AGREEMENT WITH ALFOZAN HOLDING FOR AJDA | [Link](https://longbridge.com/en/news/275995528.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.